Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Dual Radionuclide Theranostic Pretargeting.

Keinänen O, Brennan JM, Membreno R, Fung K, Gangangari K, Dayts EJ, Williams CJ, Zeglis BM.

Mol Pharm. 2019 Oct 7;16(10):4416-4421. doi: 10.1021/acs.molpharmaceut.9b00746. Epub 2019 Sep 9.

PMID:
31483993
2.

Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.

Zeglis BM, Brand C, Abdel-Atti D, Carnazza KE, Cook BE, Carlin S, Reiner T, Lewis JS.

Mol Pharm. 2015 Oct 5;12(10):3575-87. doi: 10.1021/acs.molpharmaceut.5b00294. Epub 2015 Aug 31.

3.

Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy.

Membreno R, Keinänen OM, Cook BE, Tully KM, Fung KC, Lewis JS, Zeglis BM.

Mol Pharm. 2019 May 6;16(5):2259-2263. doi: 10.1021/acs.molpharmaceut.9b00062. Epub 2019 Apr 9.

PMID:
30912951
4.

Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.

Cook BE, Adumeau P, Membreno R, Carnazza KE, Brand C, Reiner T, Agnew BJ, Lewis JS, Zeglis BM.

Bioconjug Chem. 2016 Aug 17;27(8):1789-95. doi: 10.1021/acs.bioconjchem.6b00235. Epub 2016 Jul 14.

5.

Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma.

Membreno R, Cook BE, Fung K, Lewis JS, Zeglis BM.

Mol Pharm. 2018 Apr 2;15(4):1729-1734. doi: 10.1021/acs.molpharmaceut.8b00093. Epub 2018 Mar 8.

6.

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction.

Membreno R, Cook BE, Zeglis BM.

J Vis Exp. 2019 Jan 29;(143). doi: 10.3791/59041.

PMID:
30774125
7.

Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.

Houghton JL, Membreno R, Abdel-Atti D, Cunanan KM, Carlin S, Scholz WW, Zanzonico PB, Lewis JS, Zeglis BM.

Mol Cancer Ther. 2017 Jan;16(1):124-133. doi: 10.1158/1535-7163.MCT-16-0503. Epub 2016 Nov 9.

8.

Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.

Rondon A, Schmitt S, Briat A, Ty N, Maigne L, Quintana M, Membreno R, Zeglis BM, Navarro-Teulon I, Pouget JP, Chezal JM, Miot-Noirault E, Moreau E, Degoul F.

Theranostics. 2019 Sep 19;9(22):6706-6718. doi: 10.7150/thno.35461. eCollection 2019.

9.

Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging.

Edem PE, Sinnes JP, Pektor S, Bausbacher N, Rossin R, Yazdani A, Miederer M, Kjær A, Valliant JF, Robillard MS, Rösch F, Herth MM.

EJNMMI Res. 2019 May 28;9(1):49. doi: 10.1186/s13550-019-0520-y.

10.

A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.

Zeglis BM, Sevak KK, Reiner T, Mohindra P, Carlin SD, Zanzonico P, Weissleder R, Lewis JS.

J Nucl Med. 2013 Aug;54(8):1389-96. doi: 10.2967/jnumed.112.115840. Epub 2013 May 24.

11.

DOTA-tetrazine probes with modified linkers for tumor pretargeting.

Läppchen T, Rossin R, van Mourik TR, Gruntz G, Hoeben FJM, Versteegen RM, Janssen HM, Lub J, Robillard MS.

Nucl Med Biol. 2017 Dec;55:19-26. doi: 10.1016/j.nucmedbio.2017.09.001. Epub 2017 Sep 14.

PMID:
29028502
12.

Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.

Houghton JL, Zeglis BM, Abdel-Atti D, Sawada R, Scholz WW, Lewis JS.

J Nucl Med. 2016 Mar;57(3):453-9. doi: 10.2967/jnumed.115.163824. Epub 2015 Oct 15.

13.

A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.

Adumeau P, Carnazza KE, Brand C, Carlin SD, Reiner T, Agnew BJ, Lewis JS, Zeglis BM.

Theranostics. 2016 Sep 28;6(12):2267-2277. eCollection 2016.

14.

Diabody Pretargeting with Click Chemistry In Vivo.

van Duijnhoven SM, Rossin R, van den Bosch SM, Wheatcroft MP, Hudson PJ, Robillard MS.

J Nucl Med. 2015 Sep;56(9):1422-8. doi: 10.2967/jnumed.115.159145. Epub 2015 Jul 9.

15.

Dendrimer Scaffold for the Amplification of In Vivo Pretargeting Ligations.

Cook BE, Membreno R, Zeglis BM.

Bioconjug Chem. 2018 Aug 15;29(8):2734-2740. doi: 10.1021/acs.bioconjchem.8b00385. Epub 2018 Jul 18.

16.

Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.

Meyer JP, Tully KM, Jackson J, Dilling TR, Reiner T, Lewis JS.

Bioconjug Chem. 2018 Feb 21;29(2):538-545. doi: 10.1021/acs.bioconjchem.8b00028. Epub 2018 Feb 9.

17.

(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.

Meyer JP, Houghton JL, Kozlowski P, Abdel-Atti D, Reiner T, Pillarsetty NV, Scholz WW, Zeglis BM, Lewis JS.

Bioconjug Chem. 2016 Feb 17;27(2):298-301. doi: 10.1021/acs.bioconjchem.5b00504. Epub 2015 Oct 28.

18.

Metal-Free Cycloaddition Chemistry Driven Pretargeted Radioimmunotherapy Using α-Particle Radiation.

Shah MA, Zhang X, Rossin R, Robillard MS, Fisher DR, Bueltmann T, Hoeben FJM, Quinn TP.

Bioconjug Chem. 2017 Dec 20;28(12):3007-3015. doi: 10.1021/acs.bioconjchem.7b00612. Epub 2017 Nov 30.

PMID:
29129050
19.

Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.

Reiner T, Lewis JS, Zeglis BM.

J Vis Exp. 2015 Feb 3;(96):e52335. doi: 10.3791/52335.

20.

In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.

Lewis MR, Wang M, Axworthy DB, Theodore LJ, Mallet RW, Fritzberg AR, Welch MJ, Anderson CJ.

J Nucl Med. 2003 Aug;44(8):1284-92.

Supplemental Content

Support Center